were funded and what requests were not fund-
ed, except that such summary shall not include 
specific information on any individual requests. 
‘‘(D) A general assessment of the future 
needs of the program, based on expected 
changes in threats, expected technologies, and 
likely need from potential recipients. 
‘‘(E) An assessment of the effectiveness of 
the technologies transferred, based in part on 
the evaluations provided by the recipients, with 
a recommendation whether the technology 
should continue to be offered through the pro-
gram.’’. 
(c) ASSISTANCE FROM SECRETARY OF HOMELAND 
SECURITY.—Section 708(d) (21 U.S.C. 1707(d)) is 
amended by inserting ‘‘, the Secretary of Homeland Secu-
rity,’’ after ‘‘The Secretary of Defense’’. 
TITLE V—NATIONAL YOUTH 
MEDIA CAMPAIGN 
SEC. 501. NATIONAL YOUTH ANTI-DRUG MEDIA CAMPAIGN. 
(a) IN GENERAL.—Section 709 (21 U.S.C. 1708) is 
amended to read as follows: 
‘‘SEC. 709. NATIONAL YOUTH ANTI-DRUG MEDIA CAMPAIGN. 
‘‘(a) IN GENERAL.—The Director shall conduct a na-
tional youth anti-drug media campaign (referred to in this
subtitle as the ‘national media campaign’) in accordance 
with this section for the purposes of—
‘‘(1) preventing drug abuse among young peo-
ple in the United States; 
‘‘(2) increasing awareness of adults of the im-
pact of drug abuse on young people; and 
‘‘(3) encouraging parents and other interested 
adults to discuss with young people the dangers of 
illegal drug use. 
‘‘(b) USE OF FUNDS.—
‘‘(1) IN GENERAL.—Amounts made available to 
carry out this section for the national media cam-
paign may only be used for the following: 
‘‘(A) The purchase of media time and 
space, including the strategic planning for, and 
accounting of, such purchases. 
‘‘(B) Creative and talent costs, consistent 
with paragraph (2)(A). 
‘‘(C) Advertising production costs. 
‘‘(D) Testing and evaluation of advertising. 
‘‘(E) Evaluation of the effectiveness of the 
national media campaign. 
‘‘(F) The negotiated fees for the winning 
bidder on requests for proposals issued either 
by the Office or its designee to enter into con-
tracts to carry out activities authorized by this 
section. 
‘‘(G) Partnerships with professional and 
civic groups, community-based organizations, 
including faith-based organizations, and govern-
ment organizations related to the national 
media campaign. 
‘‘(H) Entertainment industry outreach, 
interactive outreach, media projects and activi-
ties, public information, news media outreach, 
and corporate sponsorship and participation. 
‘‘(I) Operational and management ex-
penses. 
‘‘(2) SPECIFIC REQUIREMENTS.—
‘‘(A) CREATIVE SERVICES.—
‘‘(i) In using amounts for creative and 
talent costs under paragraph (1)(B), the 
Director shall use creative services donated 
at no cost to the Government (including 
creative services provided by the Partner-
ship for a Drug-Free America) wherever 
feasible and may only procure creative 
services for advertising—
‘‘(I) responding to high-priority 
or emergent campaign needs that can-
not timely be obtained at no cost; or 
‘‘(II) intended to reach a minor-
ity, ethnic, or other special audience 
that cannot reasonably be obtained at 
no cost; or 
‘‘(III) the Director determines 
that the Partnership for a Drug-Free 
America is unable to provide, pursu-
ant to subsection (d)(2)(B). 
‘‘(ii) Subject to the availability of ap-
propriations, no more than $1,500,000 
may be expended under this section each 
fiscal year on creative services, except that 
the Director may expend up to $2,000,000 
in a fiscal year on creative services to meet 
urgent needs of the national media cam-
paign with advance approval from the 
Committee on Appropriations of the Sen-
ate and of the House of Representatives 
upon a showing of the circumstances caus-
ing such urgent needs of the national 
media campaign.
‘‘(B) TESTING AND EVALUATION OF AD-
VERTISING.—In using amounts for testing and 
evaluation of advertising under paragraph 
(1)(D), the Director shall test all advertise-
ments prior to use in the national media cam-
paign to ensure that the advertisements are ef-
fective and meet industry-accepted standards. 
The Director may waive this requirement for 
advertisements using no more than 10 percent 
of the purchase of advertising time purchased 
under this section in a fiscal year and no more 
than 10 percent of the advertising space pur-
chased under this section in a fiscal year, if the 
advertisements respond to emergent and time-
sensitive campaign needs or the advertisements 
will not be widely utilized in the national media 
campaign. 
‘‘(C) EVALUATION OF EFFECTIVENESS OF 
MEDIA CAMPAIGN.—In using amounts for the 
evaluation of the effectiveness of the national 
media campaign under paragraph (1)(E), the 
Director shall—
‘‘(i) designate an independent entity 
to evaluate by April 20 of each year the ef-
fectiveness of the national media campaign 
based on data from—
‘‘(I) the Monitoring the Future 
Study published by the Department of 
Health and Human Services; 
‘‘(II) 
the 
Attitude 
Tracking 
Study published by the Partnership 
for a Drug-Free America; 
‘‘(III) the National Household 
Survey on Drug Abuse; and 
‘‘(IV) other relevant studies or 
publications, as determined by the Di-
rector, including tracking and evalua-
tion data collected according to mar-
keting and advertising industry stand-
ards; and 
‘‘(ii) ensure that the effectiveness of 
the national media campaign is evaluated 
in a manner that enables consideration of 
whether the national media campaign has 
contributed to reduction of illicit drug use 
among youth and such other measures of 
evaluation as the Director determines are 
appropriate.
‘‘(3) PURCHASE
OF
ADVERTISING
TIME
AND 
SPACE.—Subject to the availability of appropria-
tions, for each fiscal year, not less than 77 percent 
of the amounts appropriated under this section shall 
be used for the purchase of advertising time and 
space for the national media campaign, subject to 
the following exceptions: 
‘‘(A) In any fiscal year for which less than 
$125,000,000 is appropriated for the national 
media campaign, not less than 72 percent of 
the amounts appropriated under this section 
shall be used for the purchase of advertising 
time and space for the national media cam-
paign. 
‘‘(B) In any fiscal year for which more 
than $195,000,000 is appropriated under this 
section, not less than 82 percent shall be used 
for advertising production costs and the pur-
chase of advertising time and space for the na-
tional media campaign. 
‘‘(c) ADVERTISING.—In carrying out this section, the 
Director shall ensure that sufficient funds are allocated 
to meet the stated goals of the national media campaign. 
‘‘(d) DIVISION
OF RESPONSIBILITIES
AND FUNC-
TIONS UNDER THE PROGRAM.—
‘‘(1) IN GENERAL.—The Director, in consulta-
tion with the Partnership for a Drug-Free America, 
shall determine the overall purposes and strategy of 
the national media campaign. 
‘‘(2) RESPONSIBILITIES.—
‘‘(A) DIRECTOR.—The Director shall be 
responsible for implementing a focused national 
media campaign to meet the purposes set forth 
in subsection (a), and shall approve—
‘‘(i) the strategy of the national media 
campaign; 
‘‘(ii) all advertising and promotional 
material used in the national media cam-
paign; and 
‘‘(iii) the plan for the purchase of ad-
vertising time and space for the national 
media campaign. 
‘‘(B) THE
PARTNERSHIP
FOR
A
DRUG-
FREE
AMERICA.—The Director shall request 
that the Partnership for a Drug-Free Amer-
ica—
‘‘(i) develop and recommend strategies 
to achieve the goals of the national media 
campaign, including addressing national 
and local drug threats in specific regions
or States, such as methamphetamine and 
ecstasy; 
‘‘(ii) create all advertising to be used 
in the national media campaign, except ad-
vertisements that are—
‘‘(I) provided by other nonprofit 
entities pursuant to subsection (f); 
‘‘(II) intended to respond to 
high-priority or emergent campaign 
needs that cannot timely be obtained 
at no cost (not including production 
costs and talent reuse payments), pro-
vided that any such advertising mate-
rial is reviewed by the Partnership for 
a Drug-Free America; 
‘‘(III) intended to reach a minor-
ity, ethnic, or other special audience 
that cannot be obtained at no cost 
(not including production costs and 
talent reuse payments), provided that 
any such advertising material is re-
viewed by the Partnership for a Drug-
Free America; or 
‘‘(IV) any other advertisements 
that the Director determines that the
Partnership for a Drug-Free America 
is unable to provide or if the Director 
determines that another entity is more 
appropriate, subject to the require-
ments of subsection (b)(2)(A) . 
If the Director determines that another entity 
is more appropriate under clause (ii)(IV), the 
Director shall notify Congress, through the 
committees of jurisdiction in the House and 
Senate, in writing, not less than 30 days prior 
to contracting with a party other than the Part-
nership for a Drug-Free America . 
‘‘(C) MEDIA
BUYING
CONTRACTOR.—The 
Director shall enter into a contract with a 
media buying contractor to plan and purchase 
advertising time and space for the national 
media campaign. The media buying contractor 
shall not provide any other service or material, 
or conduct any other function or activity which 
the Director determines should be provided by 
the Partnership for a Drug-Free America. 
‘‘(e) PROHIBITIONS.—None of the amounts made 
available under subsection (b) may be obligated or ex-
pended for any of the following:
‘‘(1) To supplant current anti-drug community-
based coalitions. 
‘‘(2) To supplant pro bono public service time 
donated by national and local broadcasting networks 
for other public service campaigns. 
‘‘(3) For partisan political purposes, or express 
advocacy in support of or to defeat any clearly iden-
tified candidate, clearly identified ballot initiative, or 
clearly identified legislative or regulatory proposal. 
‘‘(4) To fund advertising that features any 
elected officials, persons seeking elected office, cabi-
net level officials, or other Federal officials employed 
pursuant to section 213 of Schedule C of title 5, 
Code of Federal Regulations. 
‘‘(5) To fund advertising that does not contain 
a primary message intended to reduce or prevent il-
licit drug use. 
‘‘(6) To fund advertising containing a primary 
message intended to promote support for the media 
campaign or private sector contributions to the 
media campaign. 
‘‘(f) MATCHING REQUIREMENT.—
‘‘(1) IN
GENERAL.—Amounts made available 
under subsection (b) for media time and space shall 
be matched by an equal amount of non-Federal
funds for the national media campaign, or be 
matched with in-kind contributions of the same 
value. 
‘‘(2) NO-COST MATCH ADVERTISING DIRECT RE-
LATIONSHIP REQUIREMENT.—The Director shall en-
sure that at least 70 percent of no-cost match adver-
tising provided directly relates to substance abuse 
prevention consistent with the specific purposes of 
the national media campaign, except that in any fis-
cal year in which less than $125,000,000 is appro-
priated to the national media campaign, the Director 
shall ensure that at least 85 percent of no-cost 
match advertising directly relates to substance abuse 
prevention consistent with the specific purposes of 
the national media campaign. 
‘‘(3) NO-COST
MATCH
ADVERTISING
NOT
DI-
RECTLY RELATED.—The Director shall ensure that 
no-cost match advertising that does not directly re-
late to substance abuse prevention consistent with 
the purposes of the national media campaign in-
cludes a clear anti-drug message. Such message is 
not required to be the primary message of the match 
advertising. 
‘‘(g) FINANCIAL
AND
PERFORMANCE
ACCOUNT-
ABILITY.—The Director shall cause to be performed—
‘‘(1) audits and reviews of costs of the national 
media campaign pursuant to section 304C of the 
Federal Property and Administrative Services Act of 
1949 (41 U.S.C. 254d); and 
‘‘(2) an audit to determine whether the costs of 
the national media campaign are allowable under 
section 306 of such Act (41 U.S.C. 256). 
‘‘(h) REPORT
TO CONGRESS.—The Director shall 
submit on an annual basis a report to Congress that de-
scribes—
‘‘(1) the strategy of the national media cam-
paign and whether specific objectives of the media 
campaign were accomplished; 
‘‘(2) steps taken to ensure that the national 
media campaign operates in an effective and effi-
cient manner consistent with the overall strategy 
and focus of the national media campaign; 
‘‘(3) plans to purchase advertising time and 
space; 
‘‘(4) policies and practices implemented to en-
sure that Federal funds are used responsibly to pur-
chase advertising time and space and eliminate the 
potential for waste, fraud, and abuse; and
‘‘(5) all contracts entered into with a corpora-
tion, partnership, or individual working on behalf of 
the national media campaign. 
‘‘(i) LOCAL TARGET REQUIREMENT.—The Director 
shall, to the maximum extent feasible, use amounts made 
available under this section for media that focuses on, or 
includes specific information on, prevention or treatment 
resources for consumers within specific local areas. 
‘‘(j) PREVENTION OF MARIJUANA USE.—
‘‘(1) FINDINGS.—The Congress finds the fol-
lowing: 
‘‘(A) 60 percent of adolescent admissions 
for drug treatment are based on marijuana use. 
‘‘(B) Potency levels of contemporary mari-
juana, particularly hydroponically grown mari-
juana, are significantly higher than in the past, 
rising from under 1 percent of THC in the mid-
1970s to as high as 30 percent today. 
‘‘(C) Contemporary research has dem-
onstrated that youths smoking marijuana early 
in life may be up to 5 times more likely to use 
hard drugs. 
‘‘(D) Contemporary research has dem-
onstrated clear detrimental effects in adolescent
educational achievement resulting from mari-
juana use. 
‘‘(E) Contemporary research has dem-
onstrated clear detrimental effects in adolescent 
brain development resulting from marijuana 
use. 
‘‘(F) An estimated 9,000,000 Americans a 
year drive while under the influence of illegal 
drugs, including marijuana. 
‘‘(G) Marijuana smoke contains 50 to 70 
percent more of certain cancer causing chemi-
cals than tobacco smoke. 
‘‘(H) Teens who use marijuana are up to 
4 times more likely to have a teen pregnancy 
than teens who have not. 
‘‘(I) Federal law enforcement agencies 
have identified clear links suggesting that trade 
in hydroponic marijuana facilitates trade by 
criminal organizations in hard drugs, including 
heroin. 
‘‘(J) Federal law enforcement agencies 
have identified possible links between trade in 
cannabis products and financing for terrorist 
organizations.
‘‘(2) EMPHASIS
ON
PREVENTION
OF
YOUTH 
MARIJUANA USE.—In conducting advertising and ac-
tivities otherwise authorized under this section, the 
Director may emphasize prevention of youth mari-
juana use. 
‘‘(k) PREVENTION OF METHAMPHETAMINE ABUSE 
AND OTHER EMERGING DRUG ABUSE THREATS.—
‘‘(1) REQUIREMENT TO USE 10 PERCENT OF 
FUNDS
FOR
METHAMPHETAMINE
ABUSE
PREVEN-
TION.—The Director shall ensure that, of the 
amounts appropriated under this section for the na-
tional media campaign for a fiscal year, not less 
than 10 percent shall be expended solely for the ac-
tivities described subsection (b)(1) with respect to 
advertisements specifically intended to reduce the 
use of methamphetamine. 
‘‘(2) AUTHORITY TO USE FUNDS FOR OTHER 
DRUG
ABUSE
UPON
CERTIFICATION
THAT
METH-
AMPHETAMINE ABUSE FELL DURING FISCAL YEAR 
2007.—With respect to fiscal year 2008 and any fis-
cal year thereafter, if the Director certifies in writ-
ing to Congress that domestic methamphetamine 
laboratory seizures (as reported to the El Paso Intel-
ligence Center of the Drug Enforcement Administra-
tion) decreased to at least 75 percent of the 2006
level, or the Director has documented a highly, sta-
tistically significant increase in a specific drug, from 
a baseline determined by locally collected data, that 
can be defined as a local drug crisis, the Director 
may apply paragraph (1)(A) for that fiscal year with 
respect to advertisements specifically intended to re-
duce the use of such other drugs. 
‘‘(l) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to the Office to carry out 
this section, $195,000,000 for each of fiscal years 2007 
and 2008 and $210,000,000 for each of fiscal years 2009 
through 2011.’’. 
(b) REPEAL
OF SUPERSEDED PROVISIONS.—The 
Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 
et seq.) is repealed. 
TITLE 
VI—AUTHORIZATIONS 
AND EXTENSION OF TERMI-
NATION DATE 
SEC. 601. AUTHORIZATION OF APPROPRIATIONS. 
Section 714 is amended—
(1) by striking ‘‘title,’’ and inserting ‘‘title ex-
cept activities otherwise specified,’’; and 
(2) by striking ‘‘1999 through 2003’’ and in-
serting ‘‘2006 through 2010’’.
SEC. 602. EXTENSION OF TERMINATION DATE. 
Section 715(a) is amended by striking ‘‘September 
30, 2003, this title and the amendments made by this 
title’’ and inserting ‘‘September 30, 2010, this title and 
the amendments made to this title’’. 
TITLE VII—ANTI-DOPING 
AGENCY 
SEC. 701. DESIGNATION OF UNITED STATES ANTI-DOPING 
AGENCY. 
(a) DEFINITIONS.—In this title: 
(1) UNITED
STATES
OLYMPIC
COMMITTEE.—
The term ‘‘United States Olympic Committee’’ 
means the organization established by the ‘‘Ted Ste-
vens Olympic and Amateur Sports Act’’ (36 U.S.C. 
220501 et seq.). 
(2) AMATEUR
ATHLETIC
COMPETITION.—The 
term ‘‘amateur athletic competition’’ means a con-
test, game, meet, match, tournament, regatta, or 
other event in which amateur athletes compete (36 
U.S.C. 220501(b)(2)). 
(3) AMATEUR ATHLETE.—The term ‘‘amateur 
athlete’’ means an athlete who meets the eligibility 
standards established by the national governing body 
or paralympic sports organization for the sport in 
which the athlete competes (36 U.S.C. 22501(b)(1)).
(4) GENE DOPING.—The term ‘‘gene doping’’ 
means the nontherapeutic use of cells, genes, genetic 
elements, or of the modulation of gene expression, 
having the capacity to enhance athletic performance. 
(b) IN GENERAL.—The United States Anti-Doping 
Agency shall—
(1) serve as the independent anti-doping organi-
zation for the amateur athletic competitions recog-
nized by the United States Olympic Committee; 
(2) ensure that athletes participating in ama-
teur athletic activities recognized by the United 
States Olympic Committee are prevented from using 
performance-enhancing drugs, or performance-en-
hancing genetic modifications accomplished through 
gene-doping; 
(3) implement anti-doping education, research, 
testing, and adjudication programs to prevent 
United States Amateur Athletes participating in any 
activity recognized by the United States Olympic 
Committee 
from 
using 
performance-enhancing 
drugs, or performance-enhancing genetic modifica-
tions accomplished through gene-doping; 
(4) serve as the United States representative 
responsible for coordination with other anti-doping 
organizations coordinating amateur athletic competi-
tions recognized by the United States Olympic Com-
mittee to ensure the integrity of athletic competition, 
the health of the athletes and the prevention of use 
of performance-enhancing drugs, or performance-en-
hancing genetic modifications accomplished through 
gene-doping by United States amateur athletes; and 
(5) permanently include ‘‘gene doping’’ among 
any list of prohibited substances adopted by the 
Agency. 
SEC. 702. RECORDS, AUDIT, AND REPORT. 
(a) RECORDS.—The United States Anti-Doping 
Agency shall keep correct and complete records of account. 
(b) REPORT.—The United States Anti-Doping Agen-
cy shall submit an annual report to Congress which shall 
include—
(1) an audit conducted and submitted in ac-
cordance with section 10101 of title 36, United 
States Code; and 
(2) a description of the activities of the agency. 
SEC. 703. AUTHORIZATION OF APPROPRIATIONS. 
There are authorized to be appropriated to the 
United States Anti-Doping Agency—
(1) for fiscal year 2007, $9,700,000; 
(2) for fiscal year 2008, $10,300,000; 
(3) for fiscal year 2009, $10,600,000;
(4) for fiscal year 2010, $11,000,000; and 
(5) for fiscal year 2011, $11,500,000. 
TITLE VIII—DRUG-FREE 
COMMUNITIES 
SEC. 801. REAUTHORIZATION. 
(a) IN GENERAL.—Section 1024(a) of the Drug-Free 
Communities Act of 1997 (21 U.S.C. 1524(a)) is amend-
ed—
(1) in paragraph (9), by striking ‘‘and’’ after 
the semicolon; 
(2) in paragraph (10), by striking the period 
and inserting a semicolon; and 
(3) by adding at the end the following: 
‘‘(11) $109,000,000 for fiscal year 2008; 
‘‘(12) $114,000,000 for fiscal year 2009; 
‘‘(13) $119,000,000 for fiscal year 2010; 
‘‘(14) $124,000,000 for fiscal year 2011; and 
‘‘(15) $129,000,000 for fiscal year 2012.’’. 
(b) ADMINISTRATION COSTS.—Section 1024(b) of 
the Drug-Free Communities Act of 1997 (21 U.S.C. 
1524(b)) is amended to read as follows: 
‘‘(b) ADMINISTRATIVE COSTS.—
‘‘(1) LIMITATION.—Not more than 3 percent of 
the funds appropriated for this chapter may be used 
by the Office of National Control Policy to pay for
administrative costs associated with their respon-
sibilities under the chapter. 
‘‘(2) DESIGNATED AGENCY.—The agency dele-
gated to carry out this program under section 
1031(d) may use up to 5 percent of the funds allo-
cated for grants under this chapter for administra-
tive costs associated with carrying out the pro-
gram.’’. 
SEC. 802. SUSPENSION OF GRANTS. 
(a) IN GENERAL.—Section 1032(b) of the Drug-Free 
Communities Act of 1997 (21 U.S.C. 1532(b)) is amended 
by adding at the end the following: 
‘‘(4) PROCESS
FOR
SUSPENSION.—A grantee 
shall not be suspended or terminated under para-
graph (1)(A)(ii), (2)(A)(iii), or (3)(E) unless that 
grantee is afforded a fair, timely, and independent 
appeal prior to such suspension or termination.’’. 
(b) REPORT TO CONGRESS.—Not later than 60 days 
after the date of enactment of this Act, the Director of 
the Office of National Drug Control Policy shall submit 
to Congress a report detailing the appeals process required 
by section 1032(b)(4) of the Drug-Free Communities Act 
of 1997, as added by subsection (a).
SEC. 803. GRANT AWARD INCREASE. 
Subsections (b)(1)(A)(iv), (b)(2)(C)(i), and (b)(3)(F) 
of section 1032 of the Drug-Free Communities Act of 
1997 (21 U.S.C. 1532) are amended by striking 
‘‘$100,000’’ and inserting ‘‘$125,000’’. 
SEC. 804. PROHIBITION ON ADDITIONAL ELIGIBILITY CRI-
TERIA. 
Section 1032(a) of the Drug-Free Communities Act 
of 1997 (21 U.S.C. 1532(a)) is amended by adding at the 
end the following: 
‘‘(7) ADDITIONAL
CRITERIA.—The Director 
shall not impose any eligibility criteria on new appli-
cants or renewal grantees not provided in this chap-
ter.’’. 
SEC. 805. NATIONAL COMMUNITY ANTI-DRUG COALITION 
INSTITUTE. 
Section 4 of Public Law 107–82 (21 U.S.C. 1521 
note), reauthorizing the Drug-Free Communities Support 
Program, is amended—
(1) by amending subsection (a) to read as fol-
lows: 
‘‘(a) IN GENERAL.—The Director of the Office of 
National Drug Control Policy shall, using amounts au-
thorized to be appropriated by subsection (d), make a di-
rected grant to Community Anti-Drug Coalitions of Amer-
ica to provide for the continuation of the National Com-
munity Anti-drug Coalition Institute.’’; 
(2) by striking subsection (b) and redesignating 
subsections (c) and (d) as (b) and (c), respectively; 
and 
(3) in subsection (c), as redesignated by para-
graph (2), by adding at the end the following: 
‘‘(4) For each of the fiscal years 2008 through 
2012, $2,000,000.’’. 
TITLE IX—NATIONAL GUARD 
COUNTERDRUG SCHOOLS 
SEC. 901. NATIONAL GUARD COUNTERDRUG SCHOOLS. 
(a) AUTHORITY TO OPERATE.—Under such regula-
tions as the Secretary of Defense may prescribe, the Chief 
of the National Guard Bureau may establish and operate, 
or provide financial assistance to the States to establish 
and operate, not more than 5 schools (to be known gen-
erally as ‘‘National Guard counterdrug schools’’). 
(b) PURPOSE.—The purpose of the National Guard 
counterdrug schools shall be the provision by the National 
Guard of training in drug interdiction and counterdrug 
activities and drug demand reduction activities to per-
sonnel of the following: 
(1) Federal agencies.
(2) State, local, and tribal law enforcement 
agencies. 
(3) Community-based organizations engaged in 
such activities. 
(4) Other non-Federal governmental and pri-
vate entities and organizations engaged in such ac-
tivities. 
(c) COUNTERDRUG SCHOOLS SPECIFIED.—The Na-
tional Guard counterdrug schools operated under the au-
thority in subsection (a) are as follows: 
(1) The National Interagency Civil-Military In-
stitute (NICI), San Luis Obispo, California. 
(2) The Multi-Jurisdictional Counterdrug Task 
Force Training (MCTFT), St. Petersburg, Florida. 
(3) The Midwest Counterdrug Training Center 
(MCTC), Johnston, Iowa. 
(4) The Regional Counterdrug Training Acad-
emy (RCTA), Meridian, Mississippi. 
(5) The Northeast Regional Counterdrug Train-
ing Center (NCTC), Fort Indiantown Gap, Pennsyl-
vania. 
(d) USE OF NATIONAL GUARD PERSONNEL.—
(1) IN GENERAL.—To the extent provided for 
in the State drug interdiction and counterdrug ac-
tivities plan of a State in which a National Guard
counterdrug school is located, personnel of the Na-
tional Guard of that State who are ordered to per-
form full-time National Guard duty authorized 
under section 112(b) of that title 32, United States 
Code, may provide training referred to in subsection 
(b) at that school. 
(2) DEFINITION.—In this subsection, the term 
‘‘State drug interdiction and counterdrug activities 
plan’’, in the case of a State, means the current plan 
submitted by the Governor of the State to the Sec-
retary of Defense under section 112 of title 32, 
United States Code. 
(e) TREATMENT UNDER AUTHORITY TO PROVIDE 
COUNTERDRUG
SUPPORT.—The provisions of section 
1004 of the National Defense Authorization Act for Fiscal 
Year 1991 (Public Law 101–510; 10 U.S.C. 374 note) 
shall apply to any activities of a National Guard 
counterdrug school under this section that are for an 
agency referred to in subsection (a) of such section 1004 
and for a purpose set forth in subsection (b) of such sec-
tion 1004. 
(f) ANNUAL REPORTS ON ACTIVITIES.—
(1) IN GENERAL.—Not later than February 1 
each year, the Secretary of Defense shall submit to 
Congress a report on the activities of the National
Guard counterdrug schools during the preceding 
year. 
(2) CONTENTS.—Each report under paragraph 
(1) shall set forth the following: 
(A) FUNDING.—The amount made avail-
able for each National Guard counterdrug 
school during the fiscal year ending in the year 
preceding the year in which such report is sub-
mitted. 
(B) ACTIVITIES.—A description of the ac-
tivities of each National Guard counterdrug 
school during the year preceding the year in 
which such report is submitted. 
(g) AUTHORIZATION OF APPROPRIATIONS.—
(1) IN GENERAL.—There is hereby authorized 
to be appropriated for the Department of Defense 
for the National Guard for each of fiscal years 2006 
through 2010, $30,000,000 for purposes of the Na-
tional Guard counterdrug schools in such fiscal year. 
(2) CONSTRUCTION.—The amount authorized 
to be appropriated by paragraph (1) for a fiscal year 
is in addition to any other amount authorized to be 
appropriated for the Department of Defense for the 
National Guard for such fiscal year.
TITLE 
X—NATIONAL 
METH-
AMPHETAMINE 
INFORMA-
TION CLEARINGHOUSE ACT 
OF 2006
SEC. 1001. SHORT TITLE. 
This title may be cited as the ‘‘National Methamphet-
amine Information Clearinghouse Act of 2006’’. 
SEC. 1002. DEFINITIONS. 
In this title—
(1) the term ‘‘Council’’ means the National 
Methamphetamine 
Advisory 
Council 
established 
under section 1003(b)(1); 
(2) the term ‘‘drug endangered children’’ means 
children whose physical, mental, or emotional health 
are at risk because of the production, use, or other 
effects of methamphetamine production or use by 
another person; 
(3) the term ‘‘National Methamphetamine In-
formation Clearinghouse’’ or ‘‘NMIC’’ means the in-
formation clearinghouse established under section 
1003(a); and 
(4) the term ‘‘qualified entity’’ means a State, 
local, or tribal government, school board, or public 
health, law enforcement, nonprofit, community anti-
drug coalition, or other nongovernmental organiza-
tion 
providing 
services 
related 
to 
methamphetamines. 
SEC. 1003. ESTABLISHMENT OF CLEARINGHOUSE AND AD-
VISORY COUNCIL. 
(a) CLEARINGHOUSE.—There is established, under 
the supervision of the Attorney General of the United 
States, an information clearinghouse to be known as the 
National Methamphetamine Information Clearinghouse. 
(b) ADVISORY COUNCIL.—
(1) IN GENERAL.—There is established an advi-
sory council to be known as the National Meth-
amphetamine Advisory Council. 
(2) MEMBERSHIP.—The Council shall consist of 
10 members appointed by the Attorney General—
(A) not fewer than 3 of whom shall be rep-
resentatives of law enforcement agencies; 
(B) not fewer than 4 of whom shall be rep-
resentatives of nongovernmental and nonprofit 
organizations providing services or training and 
implementing programs or strategies related to 
methamphetamines; and 
(C) 1 of whom shall be a representative of 
the Department of Health and Human Services. 
(3) PERIOD
OF
APPOINTMENT; VACANCIES.—
Members shall be appointed for 3 years. Any va-
cancy in the Council shall not affect its powers, but 
shall be filled in the same manner as the original ap-
pointment. 
(4) PERSONNEL MATTERS.—
(A) TRAVEL EXPENSES.—The members of 
the Council shall be allowed travel expenses, in-
cluding per diem in lieu of subsistence, at rates 
authorized for employees of agencies under sub-
chapter I of chapter 57 of title 5, United States 
Code, while away from their homes or regular 
places of business in the performance of serv-
ices for the Council. 
(B) NO COMPENSATION.—The members of 
the Council shall not receive compensation for 
the performance of the duties of a member of 
the Council. 
SEC. 1004. NMIC REQUIREMENTS AND REVIEW. 
(a) IN GENERAL.—The NMIC shall promote sharing 
information regarding successful law enforcement, treat-
ment, environmental, prevention, social services, and other 
programs related to the production, use, or effects of 
methamphetamine and grants available for such pro-
grams. 
(b) COMPONENTS.—The NMIC shall include—
(1) a toll-free number; and
100
(2) a website that provides a searchable data-
base, which—
(A) provides information on the short-term 
and long-term effects of methamphetamine use; 
(B) provides information regarding meth-
amphetamine treatment and prevention pro-
grams and strategies and programs for drug 
endangered children, including descriptions of 
successful programs and strategies and contact 
information for such programs and strategies; 
(C) provides information regarding grants 
for methamphetamine-related programs, includ-
ing contact information and links to websites; 
(D) allows a qualified entity to submit 
items to be posted on the website regarding 
successful public or private programs or other 
useful information related to the production, 
use, or effects of methamphetamine; 
(E) includes a restricted section that may 
only be accessed by a law enforcement organiza-
tion that contains successful strategies, training 
techniques, and other information that the 
Council determines helpful to law enforcement 
agency efforts to identify or combat the produc-
tion, use or effects of methamphetamine;
101
(F) allows public access to all information 
not in a restricted section; and 
(G) contains any additional information 
the Council determines may be useful in identi-
fying or combating the production, use, or ef-
fects of methamphetamine. 
Thirty days after the website in paragraph (2) is oper-
ational, no funds shall be expended to continue the website 
methresources.gov. 
(c) REVIEW OF POSTED INFORMATION.—
(1) IN GENERAL.—Not later than 30 days after 
the date of submission of an item by a qualified enti-
ty, the Council shall review an item submitted for 
posting on the website described in subsection 
(b)(2)—
(A) to evaluate and determine whether the 
item, as submitted or as modified, meets the re-
quirements for posting; and 
(B) in consultation with the Attorney Gen-
eral, to determine whether the item should be 
posted in a restricted section of the website. 
(2) DETERMINATION.—Not later than 45 days 
after the date of submission of an item, the Council 
shall—
102
(A) post the item on the website described 
in subsection (b)(2); or 
(B) notify the qualified entity that sub-
mitted the item regarding the reason such item 
shall not be posted and modifications, if any, 
that the qualified entity may make to allow the 
item to be posted. 
SEC. 1005. AUTHORIZATION OF APPROPRIATIONS. 
There are authorized to be appropriated—
(1) for fiscal year 2007—
(A) $500,000 to establish the NMIC and 
Council; and 
(B) such sums as are necessary for the op-
eration of the NMIC and Council; and 
(2) for each of fiscal years 2008 and 2009, 
such sums as are necessary for the operation of the 
NMIC and Council. 
TITLE XI—MISCELLANEOUS 
PROVISIONS 
SEC. 1101. REPEALS. 
(a) ACT.—Section 710 is repealed. 
(b) FORFEITURE ASSETS.—Section 6073 of the As-
sets Forfeiture Amendments Act of 1988 (21 U.S.C. 
1509) is repealed.
103
SEC. 1102. CONTROLLED SUBSTANCES ACT AMENDMENTS. 
Section 303(g)(2) of the Controlled Substances Act 
(21 U.S.C. 823(g)(2)) is amended—
(1) in subparagraph (B)(iii), by striking ‘‘ex-
cept that the’’ and inserting the following: ‘‘unless, 
not sooner than 1 year after the date on which the 
practitioner submitted the initial notification, the 
practitioner submits a second notification to the Sec-
retary of the need and intent of the practitioner to 
treat up to 100 patients. A second notification under 
this clause shall contain the certifications required 
by clauses (i) and (ii) of this subparagraph. The’’; 
and 
(2) in subparagraph (J)—
(A) in clause (i), by striking ‘‘thereafter’’ 
and all that follows through the period and in-
serting ‘‘thereafter.’’; 
(B) in clause (ii), by striking ‘‘Drug Addic-
tion Treatment Act of 2000’’ and inserting 
‘‘Office of National Drug Control Policy Reau-
thorization Act of 2006’’; and 
(C) in clause (iii), by striking ‘‘this para-
graph should not remain in effect, this para-
graph ceases to be in effect’’ and inserting 
‘‘subparagraph (B)(iii) should be applied by 
limiting the total number of patients a practi-
104
tioner may treat to 30, then the provisions in 
such subparagraph (B)(iii) permitting more 
than 30 patients shall not apply, effective’’. 
SEC. 1103. REPORT ON LAW ENFORCEMENT INTELLIGENCE 
SHARING. 
Not later than 180 days after the date of enactment 
of this Act, the Director shall submit to Congress a re-
port—
(1) evaluating existing and planned law enforce-
ment intelligence systems used by Federal, State, 
local, and tribal law enforcement agencies respon-
sible for drug trafficking and drug production en-
forcement; and 
(2) addressing—
(A) the current law enforcement intel-
ligence systems used by Federal, State, local, 
and tribal law enforcement agencies; 
(B) the compatibility of such systems in 
ensuring access and availability of law enforce-
ment intelligence to Federal, State, local, and 
tribal law enforcement; 
(C) the extent to which Federal, State, 
local, and tribal law enforcement are sharing 
law enforcement intelligence information to as-
105
sess current threats and design appropriate en-
forcement strategies; and 
(D) the measures needed to ensure and to 
promote effective information sharing among 
law enforcement intelligence systems operated 
by Federal, State, local, and tribal law enforce-
ment agencies responsible for drug trafficking 
and drug production enforcement. 
SEC. 1104. REQUIREMENT FOR SOUTH AMERICAN HEROIN 
STRATEGY. 
(a) IN GENERAL.—Not later than 90 days after the 
date of enactment of this Act, the Director, in coordina-
tion with the Secretary of State, shall submit to Congress 
a comprehensive strategy that addresses the increased 
threat from South American heroin, and in particular Co-
lombian heroin, and the emerging threat from opium 
poppy grown in Peru and often intended for transit to Co-
lumbia for processing into heroin. 
(b) CONTENTS.—The strategy submitted under sub-
section (a) shall include—
(1) opium eradication efforts to eliminate the 
problem at the source to prevent heroin from enter-
ing the stream of commerce; 
(2) interdiction and precursor chemical con-
trols;
106
(3) demand reduction and treatment; 
(4) alternative development programs, including 
direct assistance to regional governments to demobi-
lize and provide alternative livelihoods to former 
members of insurgent or other groups engaged in 
heroin, cocoa, or other illicit drug production or traf-
ficking; 
(5) efforts to inform and involve local citizens 
in the programs described in paragraphs (1) through 
(4), such as through leaflets advertising rewards for 
information; and 
(6) an assessment of the specific level of fund-
ing and resources necessary to simultaneously ad-
dress the threat from South American heroin and 
the threat from Colombian and Peruvian coca. 
(c) TREATMENT OF CLASSIFIED OR LAW ENFORCE-
MENT SENSITIVE INFORMATION.—Any content of the 
strategy submitted under subsection (a) that involves in-
formation classified under criteria established by an Exec-
utive order, or whose public disclosure, as determined by 
the Director or the head of any relevant Federal agency, 
would be detrimental to the law enforcement of national 
security activities of any Federal, foreign, or international 
agency, shall be presented to Congress separately from the 
rest of the strategy.
107
SEC. 1105. MODEL ACTS. 
(a) IN GENERAL.—The Director of the Office of Na-
tional Drug Control Policy shall provide for or shall enter 
into an agreement with a non-profit corporation that is 
described in section 501(c)(3) of the Internal Revenue 
Code of 1986 and exempt from tax under section 501(a) 
of such Code to—
(1) advise States on establishing laws and poli-
cies to address alcohol and other drug issues, based 
on the model State drug laws developed by the 
President’s Commission on Model State Drug Laws 
in 1993; and 
(2) revise such model State drug laws and draft 
supplementary model State laws to take into consid-
eration changes in the alcohol and drug abuse prob-
lems in the State involved. 
(b) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to carry out this subsection 
$1,500,000 for each of fiscal years 2007 through 2011. 
SEC. 1106. STUDY ON IATROGENIC ADDICTION ASSOCIATED 
WITH 
PRESCRIPTION 
OPIOID 
ANALGESIC 
DRUGS. 
(a) IN GENERAL.—
(1) STUDY.—The Director of the Office of Na-
tional Drug Control Policy shall request the Insti-
tute of Medicine of the National Academy of
108
Sciences to enter into an agreement under which the 
Institute agrees to study certain aspects of iatro-
genic addiction to prescription opioid analgesics in-
cluded in schedules II and III of the Controlled Sub-
stances Act (21 U.S.C. 812). 
(2) IATROGENIC ADDICTION.—In this section, 
the term ‘‘iatrogenic addiction’’ means an addiction 
developed from the use of an opioid analgesic by an 
individual with no previous history of any addiction, 
who has lawfully obtained and used the drug for a 
legitimate medical purpose by administration from, 
or pursuant to the prescription or order of, an indi-
vidual practitioner acting in the usual course of pro-
fessional practice. 
(b) REQUIREMENTS.—The study conducted pursuant 
to this section shall assess the current scientific literature 
to determine, if possible—
(1) the rate of iatrogenic addiction associated 
with the appropriate use of prescription drugs de-
scribed in subsection (a); 
(2) the impact of iatrogenic addiction associated 
with the appropriate use of prescription drugs de-
scribed in subsection (a) on the individual, the pre-
scriber, other patients, and society in general;
109
(3) the comparative abuse liability of prescrip-
tion drugs described in subsection (a) when used 
properly by the ultimate user for a legitimate med-
ical purpose; and 
(4)(A) what types of prospective or retrospec-
tive studies should be undertaken to determine the 
rate of iatrogenic addiction associated with the ap-
propriate use of the prescription drugs described in 
subsection (a); and 
(B) a feasible timeline for conducting and re-
porting such studies, should the current state of the 
scientific literature be insufficient to determine the 
rate, impact, and comparative abuse liability of pre-
scription drugs described in subsection (a). 
(c) REPORT.—Not later than 1 year after the date 
of enactment of this Act, the Director of the Office of Na-
tional Drug Control Policy shall ensure that the agree-
ment under subsection (a) provides for the submission of 
a report to the Congress on the status of the study con-
ducted pursuant to this section. 
SEC. 1107. REQUIREMENT FOR STRATEGY TO STOP INTER-
NET ADVERTISING OF PRESCRIPTION MEDI-
CINES WITHOUT A PRESCRIPTION. 
Not later than 120 days after the date of the enact-
ment of this Act, the Director of the Office of National
110
Drug Control Policy shall submit to Congress a strategy 
to stop advertisements that provide information about ob-
taining over the Internet drugs (as defined in section 
702(3) of the Office of National Drug Control Policy Re-
authorization Act of 1998) for which a prescription is re-
quired without the use of such a lawful prescription. 
SEC. 1108. REQUIREMENT FOR STUDY ON DIVERSION AND 
INAPPROPRIATE 
USES 
OF 
PRESCRIPTION 
DRUGS. 
Not later than 90 days after the date of enactment 
of this Act, the Director of the Office of National Drug 
Control Policy, in consultation with the Secretary of 
Health and Human Services, shall submit to Congress a 
report that includes a plan to conduct a study on the ille-
gal diversion and inappropriate uses of prescription drugs, 
including the following: 
(1) Methods to utilize both public use surveys 
that are in existence as of the date of enactment of 
this Act and other surveys to provide appropriate 
baseline data on the natural history of diversion and 
abuse of prescription drugs that are included in 
schedules under the Controlled Substances Act to 
evaluate the extent and nature of potential problems 
with such use to guide corrective actions which may 
reduce such problems without unintentionally hin-
111
dering access to these drugs for legitimate medical 
purposes. Specifically, other surveys to be considered 
are those that address the abuse of these substances 
on a regional or national basis, and those that ad-
dress the diversion of these substances on a regional 
or national basis. 
(2) A scientifically based analysis of the relative 
contribution of both innate and acquired genetic fac-
tors, environmental factors, psychological factors, 
and drug characteristics that contribute to addiction 
to prescription drugs. 
SEC. 1109. REQUIREMENT FOR AFGHAN HEROIN STRATEGY. 
(a) IN GENERAL.—Not later than 90 days after the 
date of the enactment of this Act, the Director of the Of-
fice of National Drug Control Policy shall submit to the 
Congress a comprehensive strategy that addresses the in-
creased threat from Afghan heroin. 
(b) CONTENTS.—The strategy shall include—
(1) opium crop eradication efforts to eliminate 
the problem at the source to prevent heroin from en-
tering the stream of commerce; 
(2) destruction or other direct elimination of 
stockpiles of heroin and raw opium, and heroin pro-
duction and storage facilities;
112
(3) interdiction and precursor chemical con-
trols; 
(4) demand reduction and treatment; 
(5) alternative development programs; 
(6) measures to improve cooperation and co-
ordination between Federal Government agencies, 
and between such agencies, agencies of foreign gov-
ernments, and international organizations with re-
sponsibility for the prevention of heroin production 
in, or trafficking out of, Afghanistan; and 
(7) an assessment of the specific level of fund-
ing and resources necessary significantly to reduce 
the production and trafficking of heroin. 
(c) TREATMENT OF CLASSIFIED OR LAW ENFORCE-
MENT SENSITIVE INFORMATION.—Any content of the 
strategy that involves information classified under criteria 
established by an Executive order, or whose public disclo-
sure, as determined by the Director or the head of any 
relevant Federal agency, would be detrimental to the law 
enforcement or national security activities of any Federal, 
foreign, or international agency, shall be presented to Con-
gress separately from the rest of the strategy.
113
SEC. 1110. REQUIREMENT FOR SOUTHWEST BORDER COUN-
TERNARCOTICS STRATEGY. 
(a) IN GENERAL.—Not later than 120 days after the 
date of enactment of this Act, and every 2 years there-
after, the Director of National Drug Control Policy shall 
submit to the Congress a Southwest Border Counter-
narcotics Strategy. 
(b) PURPOSES.—The Southwest Border Counter-
narcotics Strategy shall—
(1) set forth the Government’s strategy for pre-
venting the illegal trafficking of drugs across the 
international border between the United States and 
Mexico, including through ports of entry and be-
tween ports of entry on that border; 
(2) state the specific roles and responsibilities 
of the relevant National Drug Control Program 
agencies (as defined in section 702 of the Office of 
National Drug Control Policy Reauthorization Act of 
1998 (21 U.S.C. 1701)) for implementing that strat-
egy; and 
(3) identify the specific resources required to 
enable the relevant National Drug Control Program 
agencies to implement that strategy. 
(c) SPECIFIC CONTENT RELATED TO DRUG TUN-
NELS BETWEEN THE UNITED STATES AND MEXICO.—
114
The Southwest Border Counternarcotics Strategy shall in-
clude—
(1) a strategy to end the construction and use 
of tunnels and subterranean passages that cross the 
international border between the United States and 
Mexico for the purpose of illegal trafficking of drugs 
across such border; and 
(2) recommendations for criminal penalties for 
persons who construct or use such a tunnel or sub-
terranean passage for such a purpose. 
(d) CONSULTATION WITH OTHER AGENCIES.—The 
Director shall issue the Southwest Border Counter-
narcotics Strategy in consultation with the heads of the 
relevant National Drug Control Program agencies. 
(e) LIMITATION.—The Southwest Border Counter-
narcotics Strategy shall not change existing agency au-
thorities or the laws governing interagency relationships, 
but may include recommendations about changes to such 
authorities or laws. 
(f) REPORT TO CONGRESS.—The Director shall pro-
vide a copy of the Southwest Border Counternarcotics 
Strategy to the appropriate congressional committees (as 
defined in section 702 of the Office of National Drug Con-
trol Policy Reauthorization Act of 1998 (21 U.S.C. 
1701)), and to the Committee on Armed Services and the
115
Committee on Homeland Security of the House of Rep-
resentatives, and the Committee on Homeland Security 
and Governmental Affairs and the Committee on Armed 
Services of the Senate. 
(g) TREATMENT OF CLASSIFIED OR LAW ENFORCE-
MENT SENSITIVE INFORMATION.—Any content of the 
Southwest Border Counternarcotics Strategy that involves 
information classified under criteria established by an Ex-
ecutive order, or whose public disclosure, as determined 
by the Director or the head of any relevant National Drug 
Control Program agency, would be detrimental to the law 
enforcement or national security activities of any Federal, 
State, local, or tribal agency, shall be presented to Con-
gress separately from the rest of the strategy. 
SEC. 1111. REQUIREMENT FOR SCIENTIFIC STUDY OF 
MYCOHERBICIDE IN ILLICIT DRUG CROP 
ERADICATION. 
(a) REQUIREMENT.—Not later than 90 days after the 
date of enactment of this Act, the Director of the Office 
of National Drug Control Policy shall submit to the Con-
gress a report that includes a plan to conduct, on an expe-
dited basis, a scientific study of the use of mycoherbicide 
as a means of illicit drug crop elimination by an appro-
priate Government scientific research entity, including a 
complete and thorough scientific peer review. The study
116
shall include an evaluation of the likely human health and 
environmental impacts of mycoherbicides derived from 
fungus naturally existing in the soil. 
(b) STUDY.—The study required by this section shall 
be conducted in United States territory and not in any 
foreign country. 
SEC. 1112. REQUIREMENT FOR STUDY OF STATE PRE-
CURSOR CHEMICAL CONTROL LAWS. 
(a) STUDY.—The Director of National Drug Control 
Policy, in consultation with the National Alliance for 
Model State Drug Laws, shall conduct a study of State 
laws with respect to precursor chemical controls. 
(b) REPORT.—Not later than 6 months after the date 
of the enactment of this Act, the Director of National 
Drug Control Policy shall submit a report to Congress on 
the results of the study under subsection (a), including—
(1) a comparison of the State laws studied and 
the effectiveness of each such law; and 
(2) a list of best practices observed with respect 
to such laws. 
SEC. 1113. REQUIREMENT FOR STUDY OF DRUG ENDAN-
GERED CHILDREN PROGRAMS. 
(a) STUDY.—The Director of National Drug Control 
Policy shall conduct a study of methamphetamine-related
117
activities that are conducted by different Drug Endan-
gered Children programs administered by States. 
(b) REPORT.—Not later than 6 months after the date 
of the enactment of this Act, the Director of National 
Drug Control Policy shall submit to Congress a report on 
the results of the study under subsection (a). Such report 
shall include—
(1) an analysis of the best practices of the ac-
tivities studied; and 
(2) recommendations for establishing a national 
policy to address drug endangered children, based on 
the Drug Endangered Children programs adminis-
tered by States. 
(c) DEFINITIONS.—In this section—
(1) the term ‘‘methamphetamine-related activ-
ity’’ means any activity related to the production, 
use, or effects of methamphetamine; and 
(2) the term ‘‘drug endangered children’’ means 
children whose physical, mental, or emotional health 
are at risk because of the production, use, or effects 
of methamphetamine by another person. 
SEC. 1114. STUDY ON DRUG COURT HEARINGS IN NON-
TRADITIONAL PLACES. 
(a) FINDING.—Congress finds that encouraging drug 
courts and schools to enter into partnerships that allow
118
students to see the repercussions of drug abuse by non-
violent offenders may serve as a strong deterrent and pro-
mote demand reduction. 
(b) STUDY.—The Director of the Office of National 
Drug Control Policy shall conduct a study on drug court 
programs that conduct hearings in nontraditional public 
places, such as schools. At a minimum, the study shall 
evaluate similar programs in operation, such as the pro-
gram operated in the Fourth Judicial District Drug 
Court, in Washington County, Arkansas. 
(c) REQUIREMENT.—At the same time the President 
submits to Congress the National Drug Control Strategy 
due February 1, 2007, pursuant to section 706 of the Of-
fice of National Drug Control Policy Reauthorization Act 
of 1998, the President shall submit to Congress a report 
on the study conducted under subsection (b). The report 
shall include an evaluation of the results of the study and 
such recommendations as the President considers appro-
priate. 
(d) DEMAND REDUCTION.—In this section, the term 
‘‘demand reduction’’ has the meaning provided in section 
702(1) of the Office of National Drug Control Policy Re-
authorization Act of 1998 (21 U.S.C. 1701(1)).
119
SEC. 1115. REPORT ON TRIBAL GOVERNMENT PARTICIPA-
TION IN HIDTA PROCESS. 
(a) REPORT REQUIREMENT.—The Director of the 
Office of National Drug Control Policy shall prepare a re-
port for Congress on the representation of tribal govern-
ments in the High Intensity Drug Trafficking Areas Pro-
gram and in high intensity drug trafficking areas des-
ignated under that Program. The report shall include—
(1) a list of the tribal governments represented 
in the Program and a description of the participa-
tion by such governments in the Program; 
(2) an explanation of the rationale for the level 
of representation by such governments; and 
(3) recommendations by the Director for meth-
ods for increasing the number of tribal governments 
represented in the Program. 
(b) DEADLINE.—The report prepared under sub-
section (a) shall be submitted not later than 1 year after 
the date of the enactment of this Act. 
(c) DEFINITION.—In this section, the term ‘‘High In-
tensity Drug Trafficking Areas Program’’ means the pro-
gram established under section 707 of the Office of Na-
tional Drug Control Policy Reauthorization Act of 1998 
(21 U.S.C. 1706)
120
SEC. 1116. REPORT ON SCHOOL DRUG TESTING. 
(a) REPORT REQUIREMENT.—The Director of Na-
tional Drug Control Policy shall prepare a report on drug 
testing in schools. The report shall include a list of sec-
ondary schools that have initiated drug testing from 
among those schools that have attended conferences on 
drug testing sponsored by the Office of National Drug 
Control Policy. 
(b) DEADLINE.—Not later than 120 days after the 
date of the enactment of this Act, the Director of National 
Drug Control Policy shall submit to Congress the report 
required under subsection (a). 
SEC. 1117. REPORT ON ONDCP PERFORMANCE BONUSES. 
(a) REPORT REQUIREMENT.—The Director of Na-
tional Drug Control Policy shall prepare a report on per-
formance bonuses at the Office of National Drug Control 
Policy. The report shall include a list of employees who 
received performance bonuses, and the amount of such bo-
nuses, for the period beginning on October 1, 2004, and 
ending on the date of submission of the report. 
(b) DEADLINE.—Not later than 120 days after the 
date of the enactment of this Act, the Director of National 
Drug Control Policy shall submit to Congress the report 
required under subsection (a).
121
SEC. 1118. REQUIREMENT FOR DISCLOSURE OF FEDERAL 
SPONSORSHIP 
OF 
ALL 
FEDERAL 
ADVER-
TISING OR OTHER COMMUNICATION MATE-
RIALS. 
Section 712 is amended to read as follows: 
‘‘SEC. 712. REQUIREMENT FOR DISCLOSURE OF FEDERAL 
SPONSORSHIP 
OF 
ALL 
FEDERAL 
ADVER-
TISING OR OTHER COMMUNICATION MATE-
RIALS. 
‘‘(a) REQUIREMENT.—Each advertisement or other 
communication paid for by the Office, either directly or 
through a contract awarded by the Office, shall include 
a prominent notice informing the target audience that the 
advertisement or other communication is paid for by the 
Office. 
‘‘(b) ADVERTISEMENT
OR
OTHER
COMMUNICA-
TION.—In this section, the term ‘advertisement or other 
communication’ includes—
‘‘(1) an advertisement disseminated in any 
form, including print or by any electronic means; 
and 
‘‘(2) a communication by an individual in any 
form, including speech, print, or by any electronic 
means.’’.
122
SEC. 1119. AWARDS FOR DEMONSTRATION PROGRAMS BY 
LOCAL PARTNERSHIPS TO COERCE ABSTI-
NENCE 
IN 
CHRONIC 
HARD-DRUG 
USERS 
UNDER COMMUNITY SUPERVISION THROUGH 
THE USE OF DRUG TESTING AND SANCTIONS. 
At the end of the Act, insert the following: 
‘‘SEC. 716. AWARDS FOR DEMONSTRATION PROGRAMS BY 
LOCAL PARTNERSHIPS TO COERCE ABSTI-
NENCE 
IN 
CHRONIC 
HARD-DRUG 
USERS 
UNDER COMMUNITY SUPERVISION THROUGH 
THE USE OF DRUG TESTING AND SANCTIONS. 
‘‘(a) AWARDS REQUIRED.—The Director shall make 
competitive awards to fund demonstration programs by el-
igible partnerships for the purpose of reducing the use of 
illicit drugs by chronic hard-drug users living in the com-
munity while under the supervision of the criminal justice 
system. 
‘‘(b) USE OF AWARD AMOUNTS.—Award amounts re-
ceived under this section shall be used—
‘‘(1) to support the efforts of the agencies, or-
ganizations, and researchers included in the eligible 
partnership; 
‘‘(2) to develop and field a drug testing and 
graduated sanctions program for chronic hard-drug 
users living in the community under criminal justice 
supervision; and
123
‘‘(3) to assist individuals described in sub-
section (a) by strengthening rehabilitation efforts 
through such means as job training, drug treatment, 
or other services. 
‘‘(c) ELIGIBLE PARTNERSHIP DEFINED.—In this 
section, the term ‘eligible partnership’ means a working 
group whose application to the Director—
‘‘(1) identifies the roles played, and certifies the 
involvement of, two or more agencies or organiza-
tions, which may include—
‘‘(A) State, local, or tribal agencies (such 
as those carrying out police, probation, prosecu-
tion, courts, corrections, parole, or treatment 
functions); 
‘‘(B) Federal agencies (such as the Drug 
Enforcement Agency, the Bureau of Alcohol, 
Tobacco, Firearms, and Explosives, and United 
States Attorney offices); and 
‘‘(C) community-based organizations; 
‘‘(2) includes a qualified researcher; 
‘‘(3) includes a plan for using judicial or other 
criminal justice authority to administer drug tests to 
individuals described in subsection (a) at least twice 
a week, and to swiftly and certainly impose a known 
set of graduated sanctions for non-compliance with
124
community-release provisions relating to drug absti-
nence (whether imposed as a pre-trial, probation, or 
parole condition or otherwise); 
‘‘(4) includes a strategy for responding to a 
range of substance use and abuse problems and a 
range of criminal histories; 
‘‘(5) includes a plan for integrating data infra-
structure among the agencies and organizations in-
cluded in the eligible partnership to enable seamless, 
real-time tracking of individuals described in sub-
section (a); 
‘‘(6) includes a plan to monitor and measure 
the progress toward reducing the percentage of the 
population of individuals described in subsection (a) 
who, upon being summoned for a drug test, either 
fail to show up or who test positive for drugs. 
‘‘(d) REPORTS TO CONGRESS.—
‘‘(1) INTERIM REPORT.—Not later than June 1, 
2009, the Director shall submit to Congress a report 
that identifies the best practices in reducing the use 
of illicit drugs by chronic hard-drug users, including 
the best practices identified through the activities 
funded under this section. 
‘‘(2) FINAL REPORT.—Not later than June 1, 
2010, the Director shall submit to Congress a report
125
on the demonstration programs funded under this 
section, including on the matters specified in para-
graph (1). 
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There 
is authorized to be appropriated to carry out this section 
$4,900,000 for each of fiscal years 2007 through 2009.’’. 
SEC. 1120. POLICY RELATING TO SYRINGE EXCHANGE PRO-
GRAMS. 
Section 703(a) (21 U.S.C. 1702(a)) is amended by 
adding at the end the following: 
‘‘When developing the national drug control policy, any 
policy of the Director relating to syringe exchange pro-
grams for intravenous drug users shall be based on the 
best available medical and scientific evidence regarding 
their effectiveness in promoting individual health and pre-
venting the spread of infectious disease, and their impact 
on drug addiction and use. In making any policy relating 
to syringe exchange programs, the Director shall consult 
with the National Institutes of Health and the National 
Academy of Sciences.’’. 
Passed the House of Representatives December 7, 
2006. 
Attest:
Clerk.